|
Mar 7
|
Q4 2023 Aquestive Therapeutics Inc Earnings Call
|
|
Mar 5
|
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 5
|
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
|
|
Mar 4
|
Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?
|
|
Feb 29
|
Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know
|
|
Jan 30
|
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
|
|
Jan 26
|
Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jan 23
|
Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You Trade
|
|
Jan 18
|
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) top owners are individual investors with 60% stake, while 27% is held by institutions
|
|
Jan 17
|
Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for Investors
|
|
Jan 11
|
Here's Why Aquestive Therapeutics (AQST) Fell More Than Broader Market
|
|
Dec 27
|
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics
|
|
Dec 26
|
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?
|
|
Dec 7
|
Best Momentum Stock to Buy for December 7th
|
|
Dec 7
|
Syros (SYRS) Rises on Upbeat Initial Study Data on Tamibarotene
|
|
Dec 5
|
Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm™ (epinephrine) Sublingual Film
|
|
Dec 1
|
New Strong Buy Stocks for December 1st
|
|
Nov 29
|
Aquestive Therapeutics (AQST) Just Flashed Golden Cross Signal: Do You Buy?
|
|
Nov 28
|
Best Momentum Stocks to Buy for November 28th
|
|
Nov 28
|
New Strong Buy Stocks for November 28th
|